Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.

Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaau9240. doi: 10.1126/scitranslmed.aau9240.

PMID:
31270275
2.

Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking.

Tome ME, Jarvis CK, Schaefer CP, Jacobs LM, Herndon JM, Hunn KC, Arkwright NB, Kellohen KL, Mierau PC, Davis TP.

J Cereb Blood Flow Metab. 2018 Dec;38(12):2209-2222. doi: 10.1177/0271678X18803623. Epub 2018 Oct 22.

PMID:
30346224
3.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Sep 19;47(3):597. doi: 10.1016/j.immuni.2017.08.018. No abstract available.

4.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Aug 15;47(2):323-338.e6. doi: 10.1016/j.immuni.2017.07.014. Erratum in: Immunity. 2017 Sep 19;47(3):597.

5.

Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.

Zhang X, Kim S, Hundal J, Herndon JM, Li S, Petti AA, Soysal SD, Li L, McLellan MD, Hoog J, Primeau T, Myers N, Vickery TL, Sturmoski M, Hagemann IS, Miller CA, Ellis MJ, Mardis ER, Hansen T, Fleming TP, Goedegebuure SP, Gillanders WE.

Cancer Immunol Res. 2017 Jul;5(7):516-523. doi: 10.1158/2326-6066.CIR-16-0264. Epub 2017 Jun 15.

6.

P-glycoprotein traffics from the nucleus to the plasma membrane in rat brain endothelium during inflammatory pain.

Tome ME, Herndon JM, Schaefer CP, Jacobs LM, Zhang Y, Jarvis CK, Davis TP.

J Cereb Blood Flow Metab. 2016 Nov;36(11):1913-1928. Epub 2016 Jul 27.

7.

Human and Environmental Dangers Posed by Ongoing Global Tropospheric Aerosolized Particulates for Weather Modification.

Herndon JM.

Front Public Health. 2016 Jun 30;4:139. doi: 10.3389/fpubh.2016.00139. eCollection 2016. Retraction in: Front Public Health. 2016;4:156.

8.

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.

Jiang H, Hegde S, Knolhoff BL, Zhu Y, Herndon JM, Meyer MA, Nywening TM, Hawkins WG, Shapiro IM, Weaver DT, Pachter JA, Wang-Gillam A, DeNardo DG.

Nat Med. 2016 Aug;22(8):851-60. doi: 10.1038/nm.4123. Epub 2016 Jul 4.

9.

Evidence of Coal-Fly-Ash Toxic Chemical Geoengineering in the Troposphere: Consequences for Public Health.

Herndon JM.

Int J Environ Res Public Health. 2015 Aug 11;12(8):9375-90. doi: 10.3390/ijerph120809375. Retraction in: Int J Environ Res Public Health. 2015 Sep;12(9):10941-2.

10.

Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.

Tome ME, Schaefer CP, Jacobs LM, Zhang Y, Herndon JM, Matty FO, Davis TP.

J Neurochem. 2015 Jul;134(2):200-10. doi: 10.1111/jnc.13106. Epub 2015 Apr 21.

11.

Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

Lizarraga LE, Cholanians AB, Phan AV, Herndon JM, Lau SS, Monks TJ.

Toxicol Sci. 2015 Jan;143(1):209-19. doi: 10.1093/toxsci/kfu222. Epub 2014 Nov 4.

12.
13.

Catechol-o-methyltransferase and 3,4-({+/-})-methylenedioxymethamphetamine toxicity.

Herndon JM, Cholanians AB, Lizarraga LE, Lau SS, Monks TJ.

Toxicol Sci. 2014 May;139(1):162-73. doi: 10.1093/toxsci/kfu035. Epub 2014 Mar 3.

14.

Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites.

Herndon JM, Cholanians AB, Lau SS, Monks TJ.

Toxicol Sci. 2014 Mar;138(1):130-8. doi: 10.1093/toxsci/kft275. Epub 2013 Dec 3.

15.

Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination.

Li L, Kim S, Herndon JM, Goedegebuure P, Belt BA, Satpathy AT, Fleming TP, Hansen TH, Murphy KM, Gillanders WE.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12716-21. doi: 10.1073/pnas.1203468109. Epub 2012 Jul 16.

16.

Cancer genome sequencing and its implications for personalized cancer vaccines.

Li L, Goedegebuure P, Mardis ER, Ellis MJ, Zhang X, Herndon JM, Fleming TP, Carreno BM, Hansen TH, Gillanders WE.

Cancers (Basel). 2011 Nov 25;3(4):4191-211. doi: 10.3390/cancers3044191.

17.

Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.

Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA, Porembka MR, Herndon JM, Eberlein TJ, Goedegebuure P, Linehan DC.

J Immunol. 2010 Oct 1;185(7):4063-71. doi: 10.4049/jimmunol.0902609. Epub 2010 Aug 30.

18.

Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.

Li L, Herndon JM, Truscott SM, Hansen TH, Fleming TP, Goedegebuure P, Gillanders WE.

Vaccine. 2010 Feb 23;28(8):1911-8. doi: 10.1016/j.vaccine.2009.10.096.

19.

Targeting immune privilege to prevent pathogenic neovascularization.

Roychoudhury J, Herndon JM, Yin J, Apte RS, Ferguson TA.

Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3560-6. doi: 10.1167/iovs.09-3890. Epub 2010 Feb 17.

20.

Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA.

Immunity. 2008 Jul 18;29(1):21-32. doi: 10.1016/j.immuni.2008.05.013.

21.

Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL.

Griffith TS, Kazama H, VanOosten RL, Earle JK Jr, Herndon JM, Green DR, Ferguson TA.

J Immunol. 2007 Mar 1;178(5):2679-87.

22.

The role of TCR engagement and activation-induced cell death in sepsis-induced T cell apoptosis.

Unsinger J, Herndon JM, Davis CG, Muenzer JT, Hotchkiss RS, Ferguson TA.

J Immunol. 2006 Dec 1;177(11):7968-73.

23.
24.

Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins.

Ferguson TA, Stuart PM, Herndon JM, Griffith TS.

Immunol Rev. 2003 Jun;193:111-23. Review.

PMID:
12752676
25.

Nuclear georeactor origin of oceanic basalt 3He/4He, evidence, and implications.

Herndon JM.

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3047-50. Epub 2003 Mar 3.

26.

TRAIL: a mechanism of tumor surveillance in an immune privileged site.

Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA.

J Immunol. 2002 Nov 1;169(9):4739-44.

27.

Deep-Earth reactor: nuclear fission, helium, and the geomagnetic field.

Hollenbach DF, Herndon JM.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11085-90. Epub 2001 Sep 18.

28.

Regulation of Fas ligand-induced apoptosis by TNF.

Elzey BD, Griffith TS, Herndon JM, Barreiro R, Tschopp J, Ferguson TA.

J Immunol. 2001 Sep 15;167(6):3049-56.

29.

Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis.

Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA.

J Exp Med. 1998 Sep 7;188(5):887-96.

30.

Medical care delivery at the 1996 Olympic Games. Centers for Disease Control and Prevention Olympics Surveillance Unit.

Wetterhall SF, Coulombier DM, Herndon JM, Zaza S, Cantwell JD.

JAMA. 1998 May 13;279(18):1463-8.

PMID:
9600481
31.

CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.

Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA.

Immunity. 1996 Jul;5(1):7-16.

32.

Substructure of the inner core of the Earth.

Herndon JM.

Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):646-8.

33.

The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye.

Griffith TS, Herndon JM, Lima J, Kahn M, Ferguson TA.

Int Immunol. 1995 Oct;7(10):1617-25.

PMID:
8562507
34.

The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.

Ferguson TA, Herndon JM.

Invest Ophthalmol Vis Sci. 1994 Jun;35(7):3085-93.

PMID:
8206727
35.

The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.

Ferguson TA, Herndon JM, Dube P.

Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2643-51.

PMID:
8163352

Supplemental Content

Loading ...
Support Center